Rosich-Soteras Arianna, Bonilla-Serrano Carolina, Llauradó-González Ma Àngels, Fernández-Bombín Alicia, Triviño-López Joselyn Abigail, Barceló-Querol Lluís, Heredia-Aguilar Laura, Frías-Martín Ma Carmen, Valverde-Bosch Montserrat, Corominas-Bosch Ma Lourdes, Domènech Ariadna
Oncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Infusion and Vascular Access Team, Hospital Clínic Barcelona, Barcelona, Spain.
J Vasc Access. 2025 Mar;26(2):432-440. doi: 10.1177/11297298231220537. Epub 2024 Jan 11.
Creating Vascular Access Teams (VAT) provides an expert nursing role that contributes to the training and continuous improvement of healthcare personnel. They can offer greater clinical safety, reducing complications and costs. Peripherally inserted central catheters (PICCs) and midline catheters (ML) can be safe and cost-effective alternatives to other types of venous access (VA). The aim of the study was to analyse our centre's VAT first 12 months of activity. The primary outcome was reported complications. Secondary outcomes were cause of catheter removal, consultancy activity and economic impact of VAT implantation.
A longitudinal, descriptive study was carried out from March 2019 to March 2020. Using consecutive sampling, all VA inserted, and all consults received were included. Patients under 18 years of age were excluded.
The VAT inserted 1257 catheters into 1056 patients (291 MLs, 966 PICCs). The mean dwell time was 14.9 days for MLs and 59.07 days for PICCs. The main reason for removing VA was end of treatment (80.7%). During VA follow-up confirmed infection was detected in 1 ML (0.3%) and nine PICCs (0.9%). Symptomatic thrombosis was reported in 2 MLs (0.7%) and 16 PICCs (1.7%). The VAT received 367 consultations, and the main reason for consultation was to resolve doubts regarding the management of VA (80.9%). The insertion of ML and PICC catheters represented annual estimated economic savings of €867,688.44€.
Our study provides a detailed analysis of VAT's activity, its relevance to clinical safety, and to efficient resource management within our hospital. It demonstrates how VAT establishment can be a safe and efficient intervention that enhances care quality.
组建血管通路团队(VAT)可提供专业护理角色,有助于医护人员的培训和持续改进。它们能提供更高的临床安全性,减少并发症和成本。外周静脉穿刺中心静脉导管(PICC)和中线导管(ML)可能是其他类型静脉通路(VA)安全且具成本效益的替代方案。本研究的目的是分析我们中心血管通路团队活动的前12个月情况。主要结局是报告的并发症。次要结局是导管拔除原因、咨询活动以及血管通路团队植入的经济影响。
从2019年3月至2020年3月进行了一项纵向描述性研究。采用连续抽样,纳入所有插入的静脉通路以及所有收到的咨询。排除18岁以下患者。
血管通路团队为1056例患者插入了1257根导管(291根中线导管,966根外周静脉穿刺中心静脉导管)。中线导管的平均留置时间为14.9天,外周静脉穿刺中心静脉导管为59.07天。拔除静脉通路的主要原因是治疗结束(80.7%)。在静脉通路随访期间,1根中线导管(0.3%)和9根外周静脉穿刺中心静脉导管(0.9%)检测到确诊感染。2根中线导管(0.7%)和16根外周静脉穿刺中心静脉导管(1.7%)报告有症状性血栓形成。血管通路团队收到367次咨询,咨询的主要原因是解决有关静脉通路管理的疑问(80.9%)。插入中线导管和外周静脉穿刺中心静脉导管估计每年节省经济成本867,688.44欧元。
我们的研究详细分析了血管通路团队的活动、其与临床安全的相关性以及在我们医院内的有效资源管理。它表明建立血管通路团队如何能够成为提高护理质量的安全有效干预措施。